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Abstract
The GET pathway, using several proteins (Gets 1–5 and probably Sgt2), posttranslationally
conducts tail-anchored (TA) proteins to the endoplasmic reticulum (ER). At the ER, TA proteins
are inserted into the lipid bilayer and then sorted and directed to their respective destinations in the
secretory pathway. Until last year, there was no structural information on any of the GET
components but now there are ten crystal structures of Get3 in a variety of nucleotide-bound states
and conformations. The structures of Get4 and a portion of Get5 also emerged in 2010. This
minireview provides a detailed comparison of the GET structures and discusses their mechanistic
relevance to TA protein insertion. It also addresses the outstanding gaps in detailed molecular
information on this system, including the structures of Get5, Sgt2, and the transmembrane
complex comprising Get1 and Get2.
Introduction
A large proportion of cellular proteins reside within membrane bilayers and pose a particular
challenge to the cell, in that they are synthesized in the aqueous cytoplasm where their
hydrophobic transmembrane portions must be protected until delivery to the requisite
membrane. For most membrane proteins, this is solved by cotranslational integration into
the bilayer. However, around five percent of human membrane proteins, including SNAREs,
signaling proteins and endoplasmic reticulum (ER) translocon components, belong to the
family of tail-anchored (TA) proteins. TA proteins are each tethered to their respective
membrane by a single transmembrane domain (TMD) at the extreme C terminus. This helix,
obscured by the ribosome during translation, is inaccessible to the signal recognition particle
(SRP), which cotranslationally directs most membrane proteins to the ER translocon for
insertion. An alternative method of targeting is thus required and this function was recently
ascribed to a complex of proteins known as GET (for guided entry of TA-proteins)
(Stefanovic and Hegde, 2007; Favaloro et al., 2008; Schuldiner et al., 2008).
Each of the proteins so far found to participate in the yeast GET pathway is a relatively
recent discovery (see Table 1). Get1 and Get2 are transmembrane proteins that bind tightly
to each other and recruit Get3 to the ER membrane (Auld et al., 2006; Schuldiner et al.,
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2008). Get3 can be isolated from cytosol in complex with Get4 and Get5 (Jonikas et al.,
2009; Chang et al., 2010). Theoretically, Get3 is in a position to transiently link these two
GET subcomplexes, which occur at the ER membrane and in the cytosol, respectively.
Alternatively, Get3 may interact with Get1/2 or Get4/5 in a mutually exclusive fashion.
While Get3 itself is always found as a homodimer and Get4/5 has recently been shown to
contain two copies of each protein (Chartron et al., 2010), the full stoichiometry of cytosolic
and membrane-associated GET complexes remains to be established. Very recent results
from Favaloro et al. (2010) in the mammalian system show that once TRC40, also known as
Asna1—mammalian Get3 equivalent (Stefanovic and Hegde, 2007, Favaloro et al., 2008), is
fully bound to a TA protein, the TMD can be inserted into the ER membrane without any
further requirement for cytosolic factors.
Genetics and biochemical data link Get4/5 with a tetratrico peptide repeat (TPR)-containing
protein, Sgt2 (Jonikas et al., 2009; Chang et al., 2010; Costanzo et al., 2010; Leznicki et al.,
2010; Battle et al., 2010), which is homologous to a vertebrate glutamine-rich TPR protein
called SGTA with roles in androgen-receptor signaling (Buchanan et al., 2007) and mitosis
(Winnefeld et al., 2006). Sgt2 also binds to the chaperones Ssa1&2 (homologs of Hsc70)
and Ydj1 (Hsp40/DnaJ-related). Bat3, which physically interacts with SGTA, is another
newly discovered player in GET-dependent TA protein insertion (Leznicki et al., 2010).
Rabu et al. (2009) delineated three mechanisms for TA-membrane insertion (Hsc70/Hsp40,
SRP, and GET), based on current experimental evidence, and these new data add support to
their speculation that these mechanisms might be closely intertwined.
The central component of the S. cerevisiae GET pathway, an ATPase formerly known as
Arr4 and now called Get3, first entered the literature in 2003 when Shen et al. described its
similarity to a bacterial arsenical resistance factor, ArsA, and its roles in metal stress (Shen
et al., 2003). It is the only eukaryotic ATPase member of the SIMIBI (for SRP, MinD, and
BioD) class of NTPases (see Leipe et al. (2002) for a review) that is dominated by GTPases,
including the main player in membrane protein insertion, the SRP. Prokaryotic ATPases in
this class include ArsA, dethiobiotin synthetase (BioD), and Nitrogenase Iron Protein
(NifH), which all feature the “deviant P loop” with a lysine in the second position (Koonin,
1993) and offer useful structural comparisons for the Get3 nucleotide cycle.
Further work (Schuldiner et al., 2005; Auld et al., 2006; Metz et al., 2006; Kao et al., 2007;
Lee and Dohlman, 2008) identified roles for Get3 in Golgi to ER traffic (the original source
of the GET acronym), the ubiquitin-proteasome system, metal homeostasis, signal
transduction, and insulin secretion. Upregulation of TRC40/Asna1, the human homolog of
Get3, has been observed in tuberculosis (Mistry et al., 2007), breast cancers (Kurdi-Haidar
et al., 1998), and ovarian cancer (Hemmingsson et al., 2009a). Inhibition of Asna1 decreases
tumor cell resistance to platinum-based therapies (Hemmingsson et al., 2009b). Epistatic
miniarray profiling first established the functional and physical association between Get3
and Get1/2 (Schuldiner et al., 2005), or Get4/5 (Jonikas et al., 2009) in the context of protein
biogenesis in the ER.
Most of these seemingly disparate functions were collectively rationalized as the result of
Get3’s role in TA-protein insertion (Stefanovic and Hegde, 2007). TA proteins have diverse
functions in membrane fusion, secretion, apoptosis, and quality control of proteins (for a
recent review, see Rabu et al. [2009]) and failure to insert them has wide-reaching
consequences, particularly under the conditions of cellular stress. These consequences
include defects in removal of terminally misfolded proteins from the ER (Schuldiner et al.,
2005) and impaired DNA damage repair (Zewail et al., 2003). Get3 is also known to bind
other proteins; e.g., Gpa1 (Lee and Dohlman, 2008) and Gef1 (Metz et al., 2006), whose
relation to TA-protein insertion is uncertain.
Simpson et al. Page 2













Since they enable protein-protein interactions, the TPR/TPR-like folds of Sgt2 and Get4
suggest that the cytosolic GET complex may serve as a scaffold to integrate TA biogenesis
with other cellular pathways. It is likely that such coordination starts upon emergence of the
TA-protein substrate from the ribosome (Rabu et al., 2009). The stress-related phenotypes of
the GET pathway mutants imply that a putative interplay between this pathway and other
chaperones becomes essential when protein biogenesis is jeopardized by unfavorable
physicochemical conditions.
Structures of Get3
Until September 2009, there was no structural information available for Get3 or any other
GET pathway component. Concurrent publication in Proceedings of the National Academy
of Sciences (Suloway et al., 2009) and Nature (Mateja et al., 2009) of Get3 crystal
structures, was swiftly followed by three further papers (Bozkurt et al., 2009; Hu et al.,
2009; Yamagata et al., 2010) that featured “open” and “closed”structures from selected
species (summarized in Table 2; examples represented in Figure 1), providing a variety of
nucleotide-bound states and insights into the mechanism of TA-protein membrane insertion.
Structural Characteristics of Get3
The Get3 structure (see Figure 1) (Suloway et al., 2009; Mateja et al., 2009; Bozkurt et al.,
2009; Hu et al., 2009; Yamagata et al., 2010) exists as a dimer held together by a zinc ion
that is tetrahedrally coordinated by cysteines 285 and 288 (S. cerevisiae numbering in the
CXXC motif). The constituent monomer consists of a nucleotide-binding domain (NBD),
which includes the dimerization interface and a methionine-rich, helical domain that renders
the dimer “open” or “closed.” “Closing” of the Get3 dimer involves the burial of
approximately 1,500 Å of additional surface area, accompanied by a ~35° rotation of the
subunits toward each other and a concomitant decrease in the distance between Mg2+-
binding sites by over 10 Å (Mateja et al., 2009; Bozkurt et al., 2009; Hu et al., 2009). In
both states, the helical domain connects via a flexible region to the NBD, whose nucleotide-
bound state appears to influence conformation.
In each case, the Get3 unit adopts the following order of secondary structure elements (13 α
helices and 7 β strands) starting from the N terminus: α1, β1, α2, β2, α3, β3, α4, α5, α6,
β4, α7, α8, α9, β5, α10, β6, α11, β7, α12, α13. The helical domain, whether “open” or
“closed,” is formed from α helices α4 to α9 and includes disordered regions in every
published structure. This reflects conformational flexibility in the helical domain, which
might gain order in the presence of a TMD or other accessory proteins. The NBD is built
from all the remaining helices and strands forming a mixed α-β fold.
The Get3 structure encompasses some canonical features (highlighted in Figure 2) of the P
loop NTPase superfamily (Koonin, 1993), including an all-parallel 7 strand beta sheet, the
“deviant” P loop (or Walker A motif for nucleotide binding with a rare lysine in the second
position) at residues 25–33, a uniquely orientated Switch I at residues 57–61, and Switch II
at residues 166–173. These dynamic switch regions bind the γ-phosphate of ATP through
two main-chain hydrogen bonds, forming a “loaded spring” that is released upon ATP
hydrolysis (Gasper et al., 2009). The A-loop for adenosine recognition occurs at residues
316–322. A TRC40 insert, which distinguishes eukaryotic and archeal versions of Get3 from
its prokaryotic homologs (Mateja et al., 2009; Borgese and Righi, 2010) and may have an
important role in TA binding, is found between α7 and α9 of the helical domain.
TMD-binding
Though we have yet to see an experimentally determined structure of Get3 bound to a TMD,
Mateja et al. (2009), Bozkurt et al. (2009), and Yamagata et al. (2010) biochemically
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analyzed the interaction between Get3 and the TMD from model TA-proteins Sec61β,
Ramp4. and Sec22p, respectively. Moreover, Suloway et al. (2009) generated a panel of
over seventy Get3 mutants to probe the TMD binding site in vivo.
A thorough mutational analysis was performed by Mateja et al. (2009), in which 24
hydrophobic amino acids punctuating the composite groove (formed by the “closed”
structure of Get3) were individually substituted for aspartate residues. Each of these mutants
was tested for binding to the TMD of Sec61β and relative ATPase activity in vitro, and was
also screened for its ability to functionally complement a Δget3 S. cerevisiae strain in vivo.
Thus, Mateja et al. (2009) pinpointed a region comprising helices α7 and α8, and
overlapping with the “TRC insert,” as the crucial site of TMD binding. These authors
suggest that the exposed hydrophobic surface of the “open” state is unsuitable for TMD
binding, whereas the “closed” form brings together the hydrophobic residues to create the
composite groove.
Suloway et al. (2009) screened a large number of Get3 mutant plasmids for their ability to
rescue the growth defects of a Δget3 yeast strain. By identifying a cluster of “loss of
function” mutations, they successfully predicted the “closed” form of Get3 shown by Mateja
et al. (2009), with a comparable binding groove for TMDs.
Bozkurt et al. (2009) took a more biophysical approach to analyzing the Get3-TMD
interaction. They first coexpressed and copurified Get3 and TA-protein Ramp4, both from
C. thermophilum, and found that the complex did not contain any nucleotide. They then
used amide hydrogen exchange mass spectrometry (HX-MS) to compare its dynamics with
those of Get3 in the “open” and “closed” states. Ramp4 shielded amide hydrogens from
exchange to deuterons in specific regions corresponding to helices α7, α8, and α9, and the
opposite effect was seen at the end of helix α6.
Yamagata et al. (2010) coexpressed GST-tagged Get3 with Sec22p and showed that the
proteins copurified on a glutathione column. They replaced nineteen residues between α7
and α9 (and hence most of the “TRC insert”) of Get3 with a Gly-Ala-Ala-Gly linker and
found that binding to Sec22p was radically reduced.
Although data from these three groups are largely consistent, there is still a lot of missing
information on the mode of Get3 binding to TMDs. The inherent flexibility of the helical
domain and its changing conformations offer scope for a complex mechanism of TMD
association that will become clearer as further atomic-level information becomes available.
Nucleotide Hydrolysis Cycle
ADP.AlF4− and AMPPNP-Mg2+ binding mimic the ATP-hydrolysis transition state and
ATP-bound forms of Get3, respectively, and adopt the “closed” conformation (Mateja et al.,
2009; Bozkurt et al., 2009). These analogs (and presumably ATP itself) associate with both
molecules in the Get3 dimer. Each nucleotide makes several contacts with the P loop and
Switch II domain of the same Get3, while simultaneously binding to the “deviant” lysine 26
of the opposing Get3 molecule in the dimer. The Switch II region is responsible for several
dimer contacts in the “closed” state, where its C-terminal half adopts a helical structure
extending α7 and shortening the preceding loop region. In the ADP.AlF4− structure, a water
molecule, coordinated by aspartate 57 in the Switch I domain, is poised for nucleophilic
attack where the γ-phosphate would be if ATP, rather than its analog, were present (Mateja
et al., 2009). However, in the AMPPNP-Mg2+ form, switches I and II are ill defined and not
within close enough proximity for ATP hydrolysis (Bozkurt et al., 2009).
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ADP-bound Get3 occurs in both “closed” (Bozkurt et al., 2009; Hu et al., 2009) and “open”
(Suloway et al., 2009; Yamagata et al., 2010) versions. In the latter, each nucleotide
discretely contacts one molecule of the dimer, and the α and β phosphate groups of ADP
still form hydrogen bonds with the side chains of threonines 33 and 32, respectively. The
“closed” ADP-bound structure described by Bozkurt et al. (2009) contains a Mg2+ ion
coordinating the two helical domains and occupies the same crystal form as their AMPPNP-
Mg2+ version.
All of the reported nucleotide-free Get3 structures exhibit the “open” form (Mateja et al.,
2009; Hu et al., 2009; Yamagata et al., 2010). Since the Get3 structures exhibit differences
and the helical domains always include poorly resolved areas, the question of “open” and
“closed” forms remains an area for debate. There could well be intermediate forms and
structural variation relating to which point in the mechanism is captured and which
accessory proteins are found bound.
Each of the Get3 papers suggests a putative mechanistic model (summarized in Figure 3) for
the correlation of TA-protein insertion with Get3 nucleotide binding and hydrolysis.
Suloway et al. (2009), Mateja et al. (2009), and Bozkurt et al. (2009) speculate that ATP-
binding first closes the Get3 dimer, increasing its affinity for TA proteins. Hu et al. (2009)
propose that TA proteins might first bind to an “open” nucleotide-free Get3 with ATP
binding then closing Get3 around the TMD in a protective fashion. Yamagata et al. (2010)
suggest Get3 exists in equilibrium between “open” and “closed” states and that binding to
TA proteins plus membrane recruitment to Get1/2 is what stabilizes the closed form. All
agree that the Get3-TA protein docks onto the membrane-bound receptor complex Get1/2
and that ATP hydrolysis dissociates Get3 from the membrane, probably resuming its “open”
form and releasing the TA protein for membrane insertion. Bozkurt et al. (2009) observed
some TA-protein membrane insertion without a requirement for ATP hydrolysis and
therefore speculate that the docking of Get3/TMD and TA-protein insertion could precede
ATP hydrolysis, which may be necessary to trigger release of the “open” form of Get3 from
the Get1/2 receptor. Further investigations are required to truly delineate this mechanism.
Structures of Get4 and Get5
January 2010 saw the publication (Chang et al., 2010) of the first structural information on
other members of the GET pathway with a crystal structure of S. cerevisiae Get4 in complex
with the N-terminal domain of Get5. Bozkurt et al. (2010) have now also solved the
structure of C. thermophilum Get4 in isolation. Chartron et al. (2010) most recently revealed
a structure of Get4 with the N-terminal of Get5 in a different crystal form with the added
information that the complex exists as a dimer (two copies of Get4 and two copies of Get5
connected via the C-terminal domains of Get5). Moreover, via mutagenesis, they identified
the Get4/5 binding interface with Get3, which occurs at the positive N-terminal face of
Get4, confirming the prediction of Bozkurt et al. (2010). Get5 consists of an ubiquitin-like
domain (Ubl), whose human homolog (Ubl4a/GDX) was structurally solved by NMR
(PDBID: 2DZI), surrounded by N- and C-terminal domains.
All three papers agree that Get4 forms an α-2-solenoid fold with resemblance to a TPR. The
structures overlap with a low rmsd, indicating that only minor structural changes occur in
Get4 upon binding to Get5. The concave face of Get4 displays little conservation but the
convex surface includes two potential binding pockets and the charged patch near the N
terminus, which binds to Get3 (Bozkurt et al., 2010). Get5N wraps snugly around Get4 so it
is curious that mammalian forms of Get5 lack this domain. Chartron et al. (2010) suggest
that, in higher eukaryotes, Get5N may be replaced with a separate protein that bridges Ubl4a
with the pertinent Get4 equivalent. Both clefts on the convex body of Get4 are occupied by
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Get5 helices in the structure of the complex or by C-terminal helices from Get4 in the
structure of Get4 alone, indicating their potential flexibility for mechanistic changes in
protecting and passing on TMDs of TA proteins. This arrangement also offers dynamic
possibilities for the changing composition of the GET subcomplexes, both with currently
identified GET proteins, and those members and accessory proteins that may still elude us.
Perspectives and Outlook
In vitro TA-protein insertion assays into rough microsomal membranes consistently showed
that a membrane-bound receptor is required for the insertion of Get3/TRC40-dependent
substrates (Stefanovic and Hegde, 2007; Favaloro et al., 2008; Schuldiner et al., 2008;
Bozkurt et al., 2009), in addition to the roles played by Get3, 4, and 5. This is likely the
unidentified mammalian counterpart of the yeast Get1/2 receptor, which still evades
structure determination by any method. Structure prediction algorithms (Kelley and
Sternberg, 2009) indicate that both Get1 and Get2 consist of multiple transmembrane helices
that present extreme challenges to the structural biologist. Both proteins also exhibit coiled-
coil forming, cytoplasmic domains on the ER membrane that are credible sites of binding to
Get3. These, along with Bat3 and Sgt2, are an obvious next step for structural studies.
Several other proteins display interactions with Get3 that await structural characterization.
In 2008, Lee and Dohlman reported binding of Get3 to Gpa1, the alpha subunit of a
pheromone-activated heterotrimeric G protein in S. cerevisiae. Their further characterization
revealed that Get3 acts as a “nonreceptor guanine nucleotide exchange factor” (nrGEF),
stabilizing the nucleotide-free form of the subunit. Metz et al. (2006) described the copper-
dependent interaction between Get3 and an intracellular CLC (voltage-gated chloride
channel) chloride-transport protein, Gef1. Further study of these binding proteins, including
structural work, will clarify whether the interactions reflect independent cellular roles for
Get3 or if they link in with TA-protein biogenesis.
All of the currently available GET structures were solved by X-ray crystallography. The
evident flexibility and dynamics of the GET proteins also make them a potentially
interesting target for NMR spectroscopy studies, in particular the exciting new methods that
have been developed for the study of larger proteins (Isaacson et al., 2007; Xu et al., 2009).
In both “open” and “closed” crystal structures of Get3, selected helices in the helical domain
and at the junction between the two domains are missing or ill defined, probably due to
conformational diversity. This region is an obvious site for examination by NMR, which
could be used to map the binding to TMDs at residue-level detail as well as probing the
nucleotide hydrolysis cycle. Moreover, if it is possible to purify intact combinations of GET
proteins from yeast, containing either the cytosolic or membrane-associated components, it
could be a viable target for electron microscopy, potentially revealing a three-dimensional
view of the complex with information on its composition, arrangement, and stoichiometry.
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Figure 1. Example GET Structures from S. cerevisiae
(A) The highest resolution (1.8 Å) Get3 “open” structure (nucleotide free) (Hu et al., 2009)
is compared with the highest resolution (2 Å) “closed” Get3 structure (ADP.AlF4− bound)
(Mateja et al., 2009). The nucleotide is shown in red, the zinc ion in orange, and the
magnesium ions in green. One of the monomers in each dimer is colored lilac and the other
is colored blue (NBD) and pink (helical domain).
(B) The structure of Get4 (gold) bound to the N-terminal domain of Get5 (red) from Chang
et al. (2010). The Get5 Ubl and C-terminal domain (for dimerization as indicated in
Chartron et al. [2010]) are shown as shapes.
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Figure 2. NBD Features
Ribbon diagram of a monomer from an S. cerevisiae Get3 dimer (built out of coordinates
from Yamagata et al. [2010]), highlighting the nucleotide binding characteristics: the all-
parallel 7 strand beta sheet (orange), the “deviant” P loop (green with the rare lysine
indicated in stick form), the uniquely orientated Switch I (purple) and Switch II (gray), the
A-loop (red), and the CXXC motif (yellow with the cysteines shown in stick form). The
TRC40 insert, unique to archeal and eukaryotic versions of this protein, is colored pink.
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Figure 3. Schematic Representation of Our Current Understanding of the GET Pathway
Aside from the interaction of TMDs with Get3, we have no molecular information on modes
of binding between proteins in this pathway. Schematic representations should therefore be
interpreted as binding events between the pictured proteins rather than specific regions
thereof. Potential nucleotide binding/hydrolysis steps are indicated; a detailed description of
the possible ways in which the nucleotide cycle couples to TA-protein insertion into
membranes can be found in the body of the text.
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Table 1
GET Pathway Components





Get1 285 Unknown Suggested: WRB
protein
N/A 25 (60) Membrane CHD5 (coiled-coil)
Get2 235 Unknown N/A Membrane
Get3 354 TRC40/Asna-1 46 (342) SIMIBI ATPase
Get4 312 Conserved edge-expressed
protein (CEE)
33 (135) TPR-like
Get5 212 Ubl4a/GDX 33 (77) Ubiquitin-like domain
Sgt2 346 SGTA 36 (202) TPR
Unknown 1126 Bat3 N/A Ubiquitin-like domain BAG domain Nuclear
localization signal
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